Episode 30: Update on Axitinib plus Pembrolizumab in Renal Cancer (KEYNOTE 426)

The Uromigos - Un pódcast de The Uromigos

Podcast artwork

Betsy Plimack discusses the updated data with a minimum of 23 months' follow up. Dr. Brian Rini and Professor Tom Powles asks what it adds. 

Visit the podcast's native language site